AWAK PD Attracts Funding
Singapore-based Awak PD won FDA breakthrough device designation after completing its first-in-human study in October 2018, with no serious adverse events, and has now raised $40M in a financing round to support late-stage clinical studies and commercialization of its portable, wearable, sorbent-based PD device.
Read the full article » | Posted 01-09-2020
Related Articles
- Kamal Shah of NephroPlus Discusses Dalysis Innovations Posted 08-16-2024
- Global Wearable Artificial Kidney Market Expected to Grow Posted 07-12-2024
- Byonyks X1: a New, Small, Portable APD Machine Posted 06-14-2024
- The Public-Private ASN, DHSS, KidneyX Partnership is 5 Years Old This Year Posted 05-09-2024